Abstract 2064P
Background
Hospitalisation is an inevitable step in the evolution of many patients with cancer, principally in advanced tumors. This study aims to describe the admissions to a medical oncology inpatient service of our University Hospital between November 2022 and April 2023.
Methods
We conducted a retrospective cross-sectional study of patients admitted to the Medical Oncology Service of Infanta Sofía University Hospital (Madrid) along six months. Database was collected from the electronic health records. The following variables were analyzed: age, sex, type of tumor, stages, origin of the admission, period of hospital stay, diagnoses, assessment by another specialities, type of discharge and readmissions.
Results
In the chosen period, 310 hospitalisations related to 223 patients were studied, because some of them were readmitted in these six months. The average age was 71.49 years, 42.9% women and 57.1% men. The average hospital stay was 10.18 days. Near 77% of the patients had advanced disease. In order of frequency, patients with lung (28.06%), colorectal (15.8%) and genitourinary (11.94%) cancer represented the most of inpatients. Mainly the patients were admitted from the Emergency Department of our Hospital (56.45%). The most prevalent reason for hospitalisation was secondary symptoms of disease progression. Infections were the cause of admission in 24.52% of the cases and 27.42% of them were from respiratory system. Other causes to take into account were the toxicity to the treatment (5.8%). As part of the multidisciplinary approach, during their hospitalisation, 5.26% inpatients required surgical assessment. Interventional radiologists treated 1.29% patients and endocrinologists providing nutritional support in 10.65% of cases. Furthermore, less than 2% of our patients were admitted to the Intensive Care Unit. Palliative Care Unit assessed 37.74% of the inpatients, which 19.35% were being previously followed-up by them. Unfortunately 15.8% of the admitted patients died. We also observed 26.45% had to be admitted again.
Conclusions
It is important to identify the reasons why patients with cancer are admitted to the Hospital because it could help to identify areas for improvement in the quality of care.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2076P - Topical diclofenac for prevention of HFS in patients receiving capecitabine monotherapy: An exploratory subgroup analysis of the D-ToRCH phase III trial
Presenter: Akhil Santhosh
Session: Poster session 06
2077P - A randomized, placebo-controlled trial assessing the efficacy and safety of the combination of superoxide dismutase, alpha lipoic acid, vitamin B12, B1, B2, B6, E, Mg, Zn and a fatty acid for 6 months in the management of chemotherapy induced neuropathic pain
Presenter: Triantafylos Didangelos
Session: Poster session 06
2078P - Evaluation of chemotherapy-induced nausea and vomiting beyond the delayed phase: Results of a survey of healthcare providers in Japan
Presenter: Florian Scotté
Session: Poster session 06
2079P - Naloxegol for the treatment of opioid-induced constipation in patients with cancer pain: A pooled analysis of real-world studies (NALOPOOL)
Presenter: Maria del Carmen Beato Zambrano
Session: Poster session 06
2080P - Incidence and risks of intravenous chemotherapy-induced neutropenia (ICIN) in oncology: A multicenter retrospective cohort study on real-life data
Presenter: Olivia Rohr
Session: Poster session 06
2081P - The therapeutic effect of anti-inflammatory tripeptide cream on hand-foot syndrome related to anticancer drugs: A prospective, randomized, placebo-controlled pilot trial
Presenter: Yaewon Yang
Session: Poster session 06
2082P - TASMAN: An international survey on the knowledge, aTtitudes and clinical pAtternsS of use of Medical Cannabis for caNcer care
Presenter: Marco Filetti
Session: Poster session 06
2083P - Association between VTE location and risk of recurrent, bleeding and death in the international prospective TESEO SEOM cancer cohort
Presenter: Rocío Martín Lozano
Session: Poster session 06
2084P - Cardiovascular (CV) mortality among metastatic cancer patients: A retrospective cohort study
Presenter: Irbaz Riaz
Session: Poster session 06
2085P - Buprenorphine use and cancer outcomes
Presenter: Nosayaba Osazuwa-Peters
Session: Poster session 06